Ann: Appendix 4E and 2019 Annual Report, page-2

Some key points and timelines for the lazy, though I suggest everyone read the full report of course.

" Mr. Bray-Stone has also attended Miracle Valley’s facility to provide growing managementsupport during its first growth cycle (which is now nearing completion for harvest)."

"Oakum expects to be operational by the end of Q3 2019"

"The first phase of the design for Siksika’s facility provides for 150 RotoGroSystems"
" The Siksika team will visit the group’s manufacturing and research and development facility ... in Q3 2019"

"Declining the right to subscribe for additional participation in Gibio is consistent with the group’s strategy pursue joint ventureswith cultivation partners in both perishable foods and lawful cannabis in lieu of capital-intensive projects. Aligning withestablished cultivation “partners” with secured funding and a clear path to operational revenue is critical to RotoGro’ssuccessful transition to sustained operational revenue supported by technology sales while striving for near term cashflowpositive operations and value appreciation to shareholders."
(Highlighted an important piece there for those who missed earlier discussions)

"TheAustralian facility will initially house several RotoGro Systems for concurrent testing for the purpose of establishing Freshero’sfirst commercial operation at the same facility during the first half of 2020. "

" However, post quarter-end, GFS provided proposals for three RotoGro sales leads inCanada and others in California, USA and Michigan, USA."
Sort of expected, but nice to see GFS putting the RotoGro name out there too.

"The group continues to work alongside WildeboerDellelce LLP and the Ontario Securities Commission to complete its dual listing, which is expected to be finalized in Q4 2019"
Regarding the CSE listing